Literature DB >> 355546

Suppression of humoral and delayed hypersensitivity responses by distinct T cell subpopulations.

R L Whisler, J D Stobo.   

Abstract

Immunization of mice with a supraoptimal dose of sheep red blood cells (SRBC) results in splenic T cell populations capable of specifically suppressing recipients' plaque forming cell (PFC) and delayed-type hypersensitivity (DTH) responses to SRBC when tested in an adoptive transfer system. By localization on discontinuous bovine serum albumin (BSA) gradients and relative sensitivity to Cytoxan, two distinct T cell subpopulations suppressing DTH reactivity were identified. One population could not be distinguished from T cells capable of inhibiting direct and indirect PFC responses. However, another population appeared quite distinct and capable of inhibiting DTH, but not PFC responses.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 355546

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systems.

Authors:  P I Lobo; C E Spencer
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

2.  Concanavalin-induced suppressor cells: characterization on the basis of corticosteroid and radiation sensitivity.

Authors:  G C Tsokos; C B Christian; J E Balow
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

3.  T cell chronic lymphocytic leukaemia with suppressor phenotype.

Authors:  F M Hofman; D Smith; W Hocking
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

4.  Immunoregulatory T-cell dysfunction in polyclonal gammopathy.

Authors:  R A Robinson; N L Abdou; N I Abdou
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

Review 5.  The use of concanavalin A to study the immunoregulation of human T cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.

Authors:  J Limpens; R J Scheper
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

7.  Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamide.

Authors:  S Gauthier-Rahman
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

8.  Long-lasting enhancement of the delayed-type hypersensitivity response to heterologous erythrocytes in mice after a single injection of cyclophosphamide.

Authors:  D H Bovbjerg; R Ader; N Cohen
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

9.  Lymphocyte suppressor cell activity in acute and chronic liver disease.

Authors:  T Kashio; R Hotta; S Kakumu
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

10.  In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration.

Authors:  H Ozer; J W Cowens; M Colvin; A Nussbaum-Blumenson; D Sheedy
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.